Dorozhkina E.G.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dorozhkina E.G. has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Agarval R.K.
LLC "Technomed Holdings", Kaliningrad, Russian Federation
2 shared publications - Danilina T.F.
Volgograd State Medical University
2 shared publications - Svetlana V. Dyachenko
Volgograd State Medical University
2 shared publications - Victoria N. Naumova
Volgograd State Medical University
2 shared publications - Yulia M. Fedotova
Volgograd State Medical University
2 shared publications - Alexey D. Mikhalchenko
Volgograd State Medical University
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Volgograd State Medical University in Journal of Volgograd State Medical University
- Vol. 23 (3) , 33-37
Experience with the use of the tacrolimus in the treatment of lichen planus of the oral mucosa
Lichen planus is one of the most common dermatoses affecting the skin and mucous membranes. The predominant hypothesis for the etiology and pathogenesis of this disease is a T-lymphocyte-mediated autoimmune process involving basal keratinocytes. Therefore, when selecting and optimizing therapy for patients with lichen planus, it is essential to use medications that suppress the production and release of inflammatory cytokines. However, most medications used for topical therapy exhibit poor adhesion to mucous membranes, which reduces their therapeutic effect and, consequently, their effectiveness. The use of mucoadhesive agents as a drug delivery system and prolongation of action allows for the optimization of topical therapy for oral mucosal lesions. Therefore, the search for adequate treatments and methods for dermatoses manifesting on the oral mucosa is a pressing issue in dental practice. The aim of this study was to evaluate the effectiveness of the tacrolimus as part of Tacropic® in the treatment of lichen planus with oral mucosal lesions. Research methodology: This article presents the experience of treating 14 patients with erosive and ulcerative lichen planus using Tacropic® 0.03 % and Tizol® mucoadhesive gel in their standard drug therapy. Patients were monitored for one month, with results recorded at follow-up intervals. Good tolerability of topical medications was observed. The results of the research: Perifocal edema, hyperemia, bleeding, and pain subsided by day 7. Complete epithelialization of erosions was achieved in 71 % (14) of patients by day 14. By the end of the clinical observation period, clinical stabilization was achieved in all patients. Conclusions: These results in treating patients with oral lichen planus may serve as a basis for further research and potential use of topical agents in dentistry.
- 15 October 2026
- Published by Volgograd State Medical University in Journal of Volgograd State Medical University
- Vol. 23 (3) , 33-37
Open AccessExperience with the use of the tacrolimus in the treatment of lichen planus of the oral mucosa
Lichen planus is one of the most common dermatoses affecting the skin and mucous membranes. The predominant hypothesis for the etiology and pathogenesis of this disease is a T-lymphocyte-mediated autoimmune process involving basal keratinocytes. Therefore, when selecting and optimizing therapy for patients with lichen planus, it is essential to use medications that suppress the production and release of inflammatory cytokines. However, most medications used for topical therapy exhibit poor adhesion to mucous membranes, which reduces their therapeutic effect and, consequently, their effectiveness. The use of mucoadhesive agents as a drug delivery system and prolongation of action allows for the optimization of topical therapy for oral mucosal lesions. Therefore, the search for adequate treatments and methods for dermatoses manifesting on the oral mucosa is a pressing issue in dental practice. The aim of this study was to evaluate the effectiveness of the tacrolimus as part of Tacropic® in the treatment of lichen planus with oral mucosal lesions. Research methodology: This article presents the experience of treating 14 patients with erosive and ulcerative lichen planus using Tacropic® 0.03 % and Tizol® mucoadhesive gel in their standard drug therapy. Patients were monitored for one month, with results recorded at follow-up intervals. Good tolerability of topical medications was observed. The results of the research: Perifocal edema, hyperemia, bleeding, and pain subsided by day 7. Complete epithelialization of erosions was achieved in 71 % (14) of patients by day 14. By the end of the clinical observation period, clinical stabilization was achieved in all patients. Conclusions: These results in treating patients with oral lichen planus may serve as a basis for further research and potential use of topical agents in dentistry.
- 30 December 2025
- Published by Media Sphere Publishing Group in Russian Journal of Stomatology
- Vol. 18 (4)
Evaluation of the effectiveness of benzydamine hydrochloride in comprehensive therapy after dental implant surgery
Objective. The aim of the study was to perform a comparative assessment of the clinical effectiveness and patient compliance of the tablet form of benzydamine hydrochloride versus conventional topical therapy in the postoperative period following dental implant surgery. Materials and methods. A prospective open-label comparative non-randomized study was conducted involving 40 patients. The main group (n=20) received Oralsept (Gedeon Richter) in the form of lozenges, while the comparison group (n=20) received standard topical treatments. Evaluation methods included patient questionnaires, the Visual Analogue Scale (VAS), and clinical examination findings. Results. Clinical efficacy indicators were comparable between the two groups. However, the main group demonstrated significantly higher compliance (95% vs. 35%; p<0.001) and a shorter mean duration of systemic analgesic use (2.1±0.3 days vs. 4.2±0.7 days; p<0.05). Conclusions. The tablet form of benzydamine hydrochloride Oralsept (Gedeon Richter) shows clinical effectiveness comparable to traditional topical therapy, while providing significant advantages in treatment adherence and reducing the duration of systemic analgesic use. The drug may be recommended for inclusion in postoperative management protocols for patients in outpatient oral surgery practice.
- 30 December 2025
- Published by Media Sphere Publishing Group in Russian Journal of Stomatology
- Vol. 18 (4)
Evaluation of the effectiveness of benzydamine hydrochloride in comprehensive therapy after dental implant surgery
Objective. The aim of the study was to perform a comparative assessment of the clinical effectiveness and patient compliance of the tablet form of benzydamine hydrochloride versus conventional topical therapy in the postoperative period following dental implant surgery. Materials and methods. A prospective open-label comparative non-randomized study was conducted involving 40 patients. The main group (n=20) received Oralsept (Gedeon Richter) in the form of lozenges, while the comparison group (n=20) received standard topical treatments. Evaluation methods included patient questionnaires, the Visual Analogue Scale (VAS), and clinical examination findings. Results. Clinical efficacy indicators were comparable between the two groups. However, the main group demonstrated significantly higher compliance (95% vs. 35%; p<0.001) and a shorter mean duration of systemic analgesic use (2.1±0.3 days vs. 4.2±0.7 days; p<0.05). Conclusions. The tablet form of benzydamine hydrochloride Oralsept (Gedeon Richter) shows clinical effectiveness comparable to traditional topical therapy, while providing significant advantages in treatment adherence and reducing the duration of systemic analgesic use. The drug may be recommended for inclusion in postoperative management protocols for patients in outpatient oral surgery practice.
- 30 December 2024
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
MODERN APPROACHES TO THE TREATMENT OF PATIENTS WITH DISTAL OCCLUSION AND TEMPOROMANDIBULAR JOINT DYSFUNCTION IN ORTHODONTIC PRACTICE. LITERATURE REVIEW
The article provides a structured review of the scientific literature on the treatment of distal occlusion and dysfunction of the temporomandibular joint (TMJ). When studying the combination of distal occlusion with TMJ dysfunction, the results show that this combined pathology is present in 28.1% of cases in adolescents and increases significantly to 57.9% in adults [24,40,45,48,20]. Orthodontists are often the first specialists to encounter TMJ dysfunction, especially because adolescents often seek orthodontic treatment during a period of active body growth. However, current clinical guidelines and national protocols lack a clear diagnostic and therapeutic pathway to address the problem of distal occlusion in young patients who already show signs of TMJ disorder [28]. For adolescent patients, orthodontists need to develop modern diagnostic and therapeutic approaches that can prevent the progression of symptoms of temporomandibular joint dysfunction. In adult cases where loss of occlusion height and TMJ dysfunction coexist, the solution requires a comprehensive approach involving close collaboration between different dentists. Thus, solving the combined pathology of distal occlusion and TMJ dysfunction in both adolescents and adults is a significant problem in orthodontic practice. As a result, the article concludes that algorithms for the treatment of this complex of pathologies are not enough. The need for a comprehensive, age-specific treatment protocol underscores the importance of interdisciplinary strategies in orthodontic practice for effective management of this complex pathology in different age groups.
- 30 December 2024
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
MODERN APPROACHES TO THE TREATMENT OF PATIENTS WITH DISTAL OCCLUSION AND TEMPOROMANDIBULAR JOINT DYSFUNCTION IN ORTHODONTIC PRACTICE. LITERATURE REVIEW
The article provides a structured review of the scientific literature on the treatment of distal occlusion and dysfunction of the temporomandibular joint (TMJ). When studying the combination of distal occlusion with TMJ dysfunction, the results show that this combined pathology is present in 28.1% of cases in adolescents and increases significantly to 57.9% in adults [24,40,45,48,20]. Orthodontists are often the first specialists to encounter TMJ dysfunction, especially because adolescents often seek orthodontic treatment during a period of active body growth. However, current clinical guidelines and national protocols lack a clear diagnostic and therapeutic pathway to address the problem of distal occlusion in young patients who already show signs of TMJ disorder [28]. For adolescent patients, orthodontists need to develop modern diagnostic and therapeutic approaches that can prevent the progression of symptoms of temporomandibular joint dysfunction. In adult cases where loss of occlusion height and TMJ dysfunction coexist, the solution requires a comprehensive approach involving close collaboration between different dentists. Thus, solving the combined pathology of distal occlusion and TMJ dysfunction in both adolescents and adults is a significant problem in orthodontic practice. As a result, the article concludes that algorithms for the treatment of this complex of pathologies are not enough. The need for a comprehensive, age-specific treatment protocol underscores the importance of interdisciplinary strategies in orthodontic practice for effective management of this complex pathology in different age groups.
- 30 November 2024
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
THE EFFECTIVENESS OF PROSTHETIC TREATMENT USING OSSTEM IMPLANTS WITH AN ULTRA-HYDROPHILIC TS SOI SURFACE (The results of our own research)
The relevance of dental rehabilitation of individuals with partial absence of teeth by dental implantation is due to the widespread prevalence of secondary adentia and the high need of the working population for restoration of chewing function and aesthetics. Treatment of the intraosseous part of the implant surface is of great importance for the process of implant osseointegration. This paper analyzes the results of prosthetics using Osstem implants in the TS SOI modification. The ultrahydrophilic rough surface of the implants of the new modification has an increased ability to attract blood and form a blood clot over the entire surface, which contributes to stable osseointegration. One of the criteria for successful treatment is the percentage of implant survival. For 173 Osstem TS SOI implants included in the study, the survival rate was 98%. The second parameter evaluated was peri-implant bone loss. Cone beam computed tomography did not reveal any foci of low bone density around the implant or bone loss at mid- and late follow-up periods of 6 and 12 months. The third evaluation criterion was implant stability. The Osstell measuring device (Osstell AB, Gothenburg, Sweden) was used for the analysis. The average primary stability of Osstem implants with the ultrahydrophilic TS SOI surface was 68.2±7.4, the average secondary stability was 74.0±5.6. The high index of biological stability of the implant in the early stages contributes to a significant decrease in the incidence of complications and a reduction in the treatment time. The formation of biological stability of the Osstem TS SOI implant with the ultrahydrophilic surface occurs within 4-5 weeks. Thus, the use of Osstem implants with the TS SOI surface contributes to an increase in the quality of implant treatment in accordance with the protocol of direct prosthetics and immediate functional loading.
- 30 November 2024
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
THE EFFECTIVENESS OF PROSTHETIC TREATMENT USING OSSTEM IMPLANTS WITH AN ULTRA-HYDROPHILIC TS SOI SURFACE (The results of our own research)
The relevance of dental rehabilitation of individuals with partial absence of teeth by dental implantation is due to the widespread prevalence of secondary adentia and the high need of the working population for restoration of chewing function and aesthetics. Treatment of the intraosseous part of the implant surface is of great importance for the process of implant osseointegration. This paper analyzes the results of prosthetics using Osstem implants in the TS SOI modification. The ultrahydrophilic rough surface of the implants of the new modification has an increased ability to attract blood and form a blood clot over the entire surface, which contributes to stable osseointegration. One of the criteria for successful treatment is the percentage of implant survival. For 173 Osstem TS SOI implants included in the study, the survival rate was 98%. The second parameter evaluated was peri-implant bone loss. Cone beam computed tomography did not reveal any foci of low bone density around the implant or bone loss at mid- and late follow-up periods of 6 and 12 months. The third evaluation criterion was implant stability. The Osstell measuring device (Osstell AB, Gothenburg, Sweden) was used for the analysis. The average primary stability of Osstem implants with the ultrahydrophilic TS SOI surface was 68.2±7.4, the average secondary stability was 74.0±5.6. The high index of biological stability of the implant in the early stages contributes to a significant decrease in the incidence of complications and a reduction in the treatment time. The formation of biological stability of the Osstem TS SOI implant with the ultrahydrophilic surface occurs within 4-5 weeks. Thus, the use of Osstem implants with the TS SOI surface contributes to an increase in the quality of implant treatment in accordance with the protocol of direct prosthetics and immediate functional loading.
- 30 June 2023
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
- p. 133-140
MASTER IN THE EDUCATIONAL TRAECTORY OF THE HEAD OF MEDICAL ORGANIZATION
The article presents arguments about some discrepancy in the requirements for the competence of a specialist in the field of healthcare organization and public health in accordance with the professional standard and the acquired knowledge and skills of students in the relevant educational programs. So, in particular, there is a wider list of knowledge and skills required for the head of a medical organization, in comparison with the competencies that a graduate in the direction of training "Health Organization and Public Health" possesses. At the same time, not only the list of competencies is insufficient, but also the depth of knowledge, which may subsequently affect the level of qualification. At the same time, at the moment, educational programs in the direction of training Management (Health Management) are becoming increasingly popular. Such graduates have more fully formed competencies in managing organizations, strategic planning, designing development programs, etc. This level of education is not noted in any way in the required educational trajectories for heads of medical organizations, however, the list of competencies required for students in such educational programs completely closes this discrepancy and the lack of knowledge and skills that arises among representatives of the leadership in the field of health care after training in residency or at primary retraining in the organization of health care and public health. As a result, it is concluded that the direction of training 38.04.02 "Management" profile "Health Management" is exactly the educational program that fully meets the requirements of the Professional Standard, and the presence of a diploma of obtaining this education should be decisive when choosing candidates for positions heads of medical organizations.
- 30 June 2023
- Published by Technomed Holdings LLC in "Medical & Pharmaceutical Journal "Pulse"
- p. 133-140
MASTER IN THE EDUCATIONAL TRAECTORY OF THE HEAD OF MEDICAL ORGANIZATION
The article presents arguments about some discrepancy in the requirements for the competence of a specialist in the field of healthcare organization and public health in accordance with the professional standard and the acquired knowledge and skills of students in the relevant educational programs. So, in particular, there is a wider list of knowledge and skills required for the head of a medical organization, in comparison with the competencies that a graduate in the direction of training "Health Organization and Public Health" possesses. At the same time, not only the list of competencies is insufficient, but also the depth of knowledge, which may subsequently affect the level of qualification. At the same time, at the moment, educational programs in the direction of training Management (Health Management) are becoming increasingly popular. Such graduates have more fully formed competencies in managing organizations, strategic planning, designing development programs, etc. This level of education is not noted in any way in the required educational trajectories for heads of medical organizations, however, the list of competencies required for students in such educational programs completely closes this discrepancy and the lack of knowledge and skills that arises among representatives of the leadership in the field of health care after training in residency or at primary retraining in the organization of health care and public health. As a result, it is concluded that the direction of training 38.04.02 "Management" profile "Health Management" is exactly the educational program that fully meets the requirements of the Professional Standard, and the presence of a diploma of obtaining this education should be decisive when choosing candidates for positions heads of medical organizations.